Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Institute of Biomedi
(OP:
MRES
)
0.0172
+0.0006 (+3.61%)
Streaming Delayed Price
Updated: 3:54 PM EST, Feb 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Institute of Biomedi
MRES: Dr. Esmarilda Dankaert Appointed Chief Innovation Officer (CINO) at M2Bio Sciences
November 25, 2024
Via
ACCESSWIRE
MRES: M2Bio Food and Beverage Refocuses Strategy: Expanding Beyond CBD to Reach Global Consumers
August 22, 2024
Via
ACCESSWIRE
MRES: M2Bio Sciences Provides Corporate Update
March 01, 2024
Via
ACCESSWIRE
MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development
February 23, 2024
Via
ACCESSWIRE
MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward
February 22, 2024
Via
ACCESSWIRE
MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward
February 09, 2024
Via
ACCESSWIRE
Real American Announces Acquisition of M2MMA from MRES
January 30, 2024
Via
ACCESSWIRE
MRES: M2MMA Gears Up for a Landmark Year in 2024
January 02, 2024
Via
ACCESSWIRE
MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park
November 15, 2023
Via
ACCESSWIRE
MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office
November 14, 2023
Via
ACCESSWIRE
African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair
November 03, 2023
Via
ACCESSWIRE
M2MMA Announces 2024 Fight Schedule and Appoints CEO
October 12, 2023
Via
ACCESSWIRE
M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements
October 02, 2023
Via
ACCESSWIRE
M2Bio Sciences Closes JDAX Acquisition
September 21, 2023
Via
ACCESSWIRE
M2Bio Sciences Pharmacology & Clinical Application of CBD
September 15, 2023
Via
ACCESSWIRE
M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update
September 13, 2023
Via
ACCESSWIRE
M2bio Sciences Announces Launch of Exclusive MMA Organization
August 17, 2023
Via
ACCESSWIRE
BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Names Veteran Financial Leader to Advisory Board
July 19, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Unveils Meticulously Crafted Line of Teas Sourced from Kenya
July 17, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
May 25, 2023
Institute of Biomedical Research (OTC: MRES) ("M2Bio Sciences'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is...
Via
TheNewswire.com
Innovative Holdings Alliance, Inc. Announces Brand License Agreement with M2Bio Sciences
March 20, 2023
Via
ACCESSWIRE
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
